Ceribell Inc (CBLL) financials

NASDAQ · Health Care

$26.58 -4.46% Close Oct 30, 2026 Live

Ceribell revenue and earnings by year

Ceribell's revenue was $89.1 million in the fiscal year to December 31, 2025, up 36.1% from the year before. Net income was -$53.4 million, -60.0% of revenue. Since the fiscal year to December 31, 2022, revenue has grown 50.9% a year on average.

RevenueNet income
-$50.0M$0$50.0M
2022202320242025

Fiscal years, each labelled by the calendar year it ended in.

Income statement, the last 4 fiscal years

In millions of US dollars except per-share figures. Each column is a fiscal year, named by the month it ended.
Fiscal year toDec 2025Dec 2024Dec 2023Dec 2022
Revenue89654526
Revenue growth36.1%44.7%74.5%—
Gross profit78573821
Gross margin87.9%86.7%84.4%82.9%
Operating income-58-40-30-36
Operating margin-65.6%-60.7%-66.4%-139.0%
Net income-53-40-29-37
Net margin-60.0%-61.8%-65.1%-143.4%
Diluted EPS-$1.46-$3.39——
Free cash flow-42-36-30-33

Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open CBLL in Markets.

How Ceribell makes money

Revenue by segment in the quarter to June 30, 2026, as the company reports it.

SegmentRevenueShare
Product$21.2M75.6%
Subscription$6.86M24.4%

See also: CBLL returns

No forecast, no recommendation. This page describes Ceribell Inc from published data; it is not advice to buy, sell or hold any security.

Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.